Analyzing the Price-to-Earnings Ratio of Adaptive Biotechnologies Corp (ADPT)
The 36-month beta value for ADPT is also noteworthy at 1.25. There are mixed opinions on the stock, with 0 analysts rating it as a
The 36-month beta value for ADPT is also noteworthy at 1.25. There are mixed opinions on the stock, with 0 analysts rating it as a
The stock of Adaptive Biotechnologies Corp (ADPT) has gone down by -0.88% for the week, with a -12.21% drop in the past month and a
Adaptive Biotechnologies Corp (NASDAQ: ADPT) has experienced a decline in its stock price by -5.01 compared to its previous closing price of 3.59. However, the
The stock of Adaptive Biotechnologies Corp (ADPT) has gone down by -15.11% for the week, with a -0.68% drop in the past month and a
The stock of Adaptive Biotechnologies Corp (NASDAQ: ADPT) has decreased by -2.81 when compared to last closing price of 4.27.Despite this, the company has seen
The public float for ADPT is 141.79M, and at present, short sellers hold a 6.21% of that float. On February 23, 2024, the average trading
The public float for ADPT is 141.49M, and currently, shorts hold a 6.23% of that float. The average trading volume for ADPT on February 15,
Adaptive Biotechnologies Corp (NASDAQ: ADPT)’s stock price has dropped by -5.31 in relation to previous closing price of 3.77. Nevertheless, the company has seen a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.